Real-World Characteristics, Treatment Patterns, and Outcomes in Adult Patients Receiving Abrocitinib for Atopic Dermatitis in China: Interim Analysis from the AHEAD Registry
中国成人特应性皮炎患者接受阿布昔替尼治疗的真实世界特征、治疗模式和结局:AHEAD注册研究的中期分析
期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-026-01655-8
Zhang, Li; Zhou, Naihui; Wu, Zhouwei; Chen, Xuejun; Zhu, Huilan; Li, Shanshan; Han, Jianwen; Miao, Guoying; Wu, Liming; Zhu, Rongfei; Lu, Jianyun; Zheng, Yue; Jiang, Xian; Cao, Xianwei; Yu, Dehou; Zhang, Siping; Ding, Yangfeng; Man, Xiaoyong; Cui, Yong; Li, Ying; Dou, Xia; Gao, Xinghua